Vigilancia de eventos adversos de la vacuna plisacárida meningocócica A y C durante una campaña de vacunación en Níger

Rodríguez, Meiby de la Caridad; Cuevas, Iván Edelberto; Mirabal, Mayelín; Ruíz, Luis.
Vaccimonitor ; 20(2)Mayo-ago. 2011. tab
Artículo en Español | CUMED | ID: cum-47092

Documentos relacionados

  1. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
  2. [Evaluation of safety of meningococcal group AC bivalent polysaccharide conjugate vaccine in children aged 5-24 months old].
  3. Patterns of meningococcal infection in Sudan with emergence of Neisseria meningitidis serogroup W135.
  4. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
  5. Expansion of Neisseria meningitidis Serogroup C Clonal Complex 10217 during Meningitis Outbreak, Burkina Faso, 2019.
  6. Quantification of each serogroup polysaccharide of Neisseria meningitidis in A/C/Y/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis.
  7. An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.
  8. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.
  9. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
  10. Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C.